These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17020686)

  • 81. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 82. [Results of using human recombinant erythropoietin in a patient treated by peritoneal dialysis complicated by chronic infection of the tunnel of the dialysis catheter].
    Wanic-Kossowska M; Grzegorzewska A; Piszczek I; Krzymański M
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):694-5. PubMed ID: 1492040
    [No Abstract]   [Full Text] [Related]  

  • 83. Erythropoietin therapy in patients with chronic renal failure.
    Pinevich AJ; Petersen J
    West J Med; 1992 Aug; 157(2):154-7. PubMed ID: 1441466
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D; Hauglustaine D; Sennesael J
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract]   [Full Text] [Related]  

  • 85. Haemoglobin targets: we were wrong, time to move on.
    Strippoli GF; Tognoni G; Navaneethan SD; Nicolucci A; Craig JC
    Lancet; 2007 Feb; 369(9559):346-50. PubMed ID: 17276756
    [No Abstract]   [Full Text] [Related]  

  • 86. Darbepoetin alfa administered every other week maintains hemoglobin levels over 52 weeks in patients with chronic kidney disease converting from once-weekly recombinant human erythropoietin: results from simplify the treatment of anemia with Aranesp (STAAR).
    Hertel J; Locay H; Scarlata D; Jackson L; Prathikanti R; Audhya P
    Am J Nephrol; 2006; 26(2):149-56. PubMed ID: 16636531
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Current issues in erythropoietin therapy of renal anemia].
    Zakar G
    Lege Artis Med; 2007 Oct; 17(10):667-73. PubMed ID: 19227596
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Erythropoietin-associated hypertensive posterior leukoencephalopathy.
    Delanty N; Vaughan C; Frucht S; Stubgen P
    Neurology; 1997 Sep; 49(3):686-9. PubMed ID: 9305323
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Reflection on EPO.
    Jensen KE; Stenver D; Nielsen B
    Int J Artif Organs; 1990 Aug; 13(8):472-3. PubMed ID: 2228288
    [No Abstract]   [Full Text] [Related]  

  • 90. Erythropoietin treatment: influence of haemoglobin concentration on dialyser creatinine clearance in haemodialysed patients.
    Zehnder C
    Nephron; 1989; 51(3):424-5. PubMed ID: 2918959
    [No Abstract]   [Full Text] [Related]  

  • 91. Treatment of anaemia in chronic renal failure.
    Beer J
    Nurs Times; 1988 Nov 23-29; 84(47):55-7. PubMed ID: 3211795
    [No Abstract]   [Full Text] [Related]  

  • 92. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM; Mooij JM; Roujouleh H
    Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
    [No Abstract]   [Full Text] [Related]  

  • 93. [The role of erythropoietin].
    Godin M
    Soins; 2004 Sep; (688 Suppl):5. PubMed ID: 15526820
    [No Abstract]   [Full Text] [Related]  

  • 94. [Anemia in heart failure. Future therapeutic target?].
    Grigorian Shamagian L; González-Juanatey JR
    Med Clin (Barc); 2007 Mar; 128(10):372-4. PubMed ID: 17386243
    [No Abstract]   [Full Text] [Related]  

  • 95. Clinical use of erythropoietin.
    Henry DH; Spivak JL
    Curr Opin Hematol; 1995 Mar; 2(2):118-24. PubMed ID: 9371981
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Recombinant human erythropoietin in children with cancer.
    MacMillan ML; Freedman MH
    J Pediatr Hematol Oncol; 1998; 20(3):187-9. PubMed ID: 9628427
    [No Abstract]   [Full Text] [Related]  

  • 97. Renal transplantation: reaping the rewards of biomedical research.
    Suthanthiran M
    Curr Opin Nephrol Hypertens; 2000 Nov; 9(6):597-8. PubMed ID: 11128420
    [No Abstract]   [Full Text] [Related]  

  • 98. Commentary: cardiomyopathy of anemia and the potential of erythropoietin.
    Foley RN; Parfrey PS
    Perit Dial Int; 1997; 17(2):117-8. PubMed ID: 9159828
    [No Abstract]   [Full Text] [Related]  

  • 99. Changes in red blood cell volume under recombinant human erythropoietin therapy.
    Schmidt R; Lerche D; Dörp E; Winkler R; Klinkmann H
    Contrib Nephrol; 1990; 87():52-8. PubMed ID: 2093541
    [No Abstract]   [Full Text] [Related]  

  • 100. Medical uses of erythropoietin.
    Littlewood T
    Vox Sang; 2004 Jul; 87 Suppl 2(Suppl 3):93-5. PubMed ID: 15209889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.